Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 22994227)

1.

Does inhibiting Sur1 complement rt-PA in cerebral ischemia?

Simard JM, Geng Z, Silver FL, Sheth KN, Kimberly WT, Stern BJ, Colucci M, Gerzanich V.

Ann N Y Acad Sci. 2012 Sep;1268:95-107. doi: 10.1111/j.1749-6632.2012.06705.x. Review.

2.

Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas.

Kunte H, Busch MA, Trostdorf K, Vollnberg B, Harms L, Mehta RI, Castellani RJ, Mandava P, Kent TA, Simard JM.

Ann Neurol. 2012 Nov;72(5):799-806. doi: 10.1002/ana.23680.

3.

Drugs acting on SUR1 to treat CNS ischemia and trauma.

Simard JM, Woo SK, Bhatta S, Gerzanich V.

Curr Opin Pharmacol. 2008 Feb;8(1):42-9. Epub 2007 Nov 26.

4.

Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8.

Woo SK, Kwon MS, Geng Z, Chen Z, Ivanov A, Bhatta S, Gerzanich V, Simard JM.

J Cereb Blood Flow Metab. 2012 Mar;32(3):525-36. doi: 10.1038/jcbfm.2011.159. Epub 2011 Nov 16.

5.

Glibenclamide in cerebral ischemia and stroke.

Simard JM, Sheth KN, Kimberly WT, Stern BJ, del Zoppo GJ, Jacobson S, Gerzanich V.

Neurocrit Care. 2014 Apr;20(2):319-33. doi: 10.1007/s12028-013-9923-1. Review.

6.

Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia.

Ortega FJ, Jolkkonen J, Mahy N, Rodríguez MJ.

J Cereb Blood Flow Metab. 2013 Mar;33(3):356-64. doi: 10.1038/jcbfm.2012.166. Epub 2012 Nov 14.

7.

Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion.

Simard JM, Kilbourne M, Tsymbalyuk O, Tosun C, Caridi J, Ivanova S, Keledjian K, Bochicchio G, Gerzanich V.

J Neurotrauma. 2009 Dec;26(12):2257-67. doi: 10.1089/neu.2009.1021.

8.

Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.

Gribble FM, Tucker SJ, Seino S, Ashcroft FM.

Diabetes. 1998 Sep;47(9):1412-8.

PMID:
9726229
9.

Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke.

Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, Tsymbalyuk N, West GA, Gerzanich V.

Nat Med. 2006 Apr;12(4):433-40. Epub 2006 Mar 19.

10.

Glibenclamide improves neurological function in neonatal hypoxia-ischemia in rats.

Zhou Y, Fathali N, Lekic T, Tang J, Zhang JH.

Brain Res. 2009 May 13;1270:131-9. doi: 10.1016/j.brainres.2009.03.010. Epub 2009 Mar 21.

PMID:
19306849
11.

Novel approaches to the primary prevention of edema after ischemia.

Sheth KN.

Stroke. 2013 Jun;44(6 Suppl 1):S136. doi: 10.1161/STROKEAHA.113.001821. No abstract available.

12.

[Glimepiride].

Nakamura N.

Nihon Rinsho. 2002 Sep;60 Suppl 9:351-6. Review. Japanese. No abstract available.

PMID:
12387017
13.

Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.

Simard JM, Tsymbalyuk O, Ivanov A, Ivanova S, Bhatta S, Geng Z, Woo SK, Gerzanich V.

J Clin Invest. 2007 Aug;117(8):2105-13.

15.

Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.

Teng F, Beray-Berthat V, Coqueran B, Lesbats C, Kuntz M, Palmier B, Garraud M, Bedfert C, Slane N, Bérézowski V, Szeremeta F, Hachani J, Scherman D, Plotkine M, Doan BT, Marchand-Leroux C, Margaill I.

Exp Neurol. 2013 Oct;248:416-28. doi: 10.1016/j.expneurol.2013.07.007. Epub 2013 Jul 20.

PMID:
23876515
16.

Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke.

Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V.

Stroke. 2009 Feb;40(2):604-9. doi: 10.1161/STROKEAHA.108.522409. Epub 2008 Nov 20.

17.

Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats.

Copin JC, Merlani P, Sugawara T, Chan PH, Gasche Y.

Exp Neurol. 2008 Sep;213(1):196-201. doi: 10.1016/j.expneurol.2008.05.022. Epub 2008 Jun 9.

18.

Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).

Hambrock A, de Oliveira Franz CB, Hiller S, Osswald H.

J Pharmacol Exp Ther. 2006 Mar;316(3):1031-7. Epub 2005 Nov 23.

19.

rt-PA causes a dose-dependent increase in the extravasation of cellular and non-cellular blood elements after focal cerebral ischemia.

Burggraf D, Martens HK, Dichgans M, Hamann GF.

Brain Res. 2007 Aug 20;1164:55-62. Epub 2007 Jun 14.

PMID:
17644075
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk